Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Worodria, William ^a,b,c   Massinga Loembe, Marguerite ^d   Mayanja Kizza, Harriet ^a,b   Namaganda, Jane ^b   Kambugu, Andrew ^b   Manabe, Yukari C ^b,e   Kestens, Luc ^c,d   Colebunders, Robert ^c,d  

^a MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^b MAKERERE UNIVERSITY   (Uganda)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; BODY MASS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; TUBERCULOSIS; ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS RELATED COMPLEX; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; UGANDA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY MASS INDEX; C-REACTIVE PROTEIN; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV; HIV SEROPOSITIVITY; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RISK FACTORS; TUBERCULOSIS; UGANDA; YOUNG ADULT;

EID: 79251582478     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/758350     Document Type: Article

References (41)

1. Corbett E. L., Watt C. J., Walker N., Maher D., Williams B. G., Raviglione M. C., Dye C., The growing burden of tuberculosis: global trends and interactions with the HIV epidemic Archives of Internal Medicine 2003 163 9 1009 1021
2. Martinson N. A., Karstaedt A., Venter W. F., Omar T., King P., Mbengo T., Marais E., McIntyre J., Chaisson R. E., Hale M., Causes of death in hospitalized adults with a premortem diagnosis of tuberculosis: an autopsy study AIDS 2007 21 15 2043 2050
3. Getahun H., Harrington M., O'Brien R., Nunn P., Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes Lancet 2007 369 9578 2042 2049
4. Reid M. J., Shah N. S., Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings Lancet Infectious Diseases 2009 9 3 173 184
5. Dorman S. E., New diagnostic tests for tuberculosis: bench, bedside, and beyond Clinical Infectious Diseases 2010 50 supplement 3 S173 S177
6. Jacob S. T., Moore C. C., Banura P., Pinkerton R., Meya D., Opendi P., Reynolds S. J., Kenya-Mugisha N., Mayanja-Kizza H., Scheld W. M., Kalisa C., Kimuli K., Nganizi A., Omongot S., Burke R., Horton C. L., Ssali F., Sekayiba S., Ddikusoka P., Severe sepsis in two Ugandan hospitals: a prospective observational study of management and outcomes in a predominantly HIV-1 infected population PLoS ONE 2009 4 11, article e7782
7. Kigozi I. M., Dobkin L. M., Martin J. N., Geng E. H., Muyindike W., Emenyonu N. I., Bangsberg D. R., Hahn J. A., Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa Journal of Acquired Immune Deficiency Syndromes 2009 52 2 280 289
8. Jerene D., Endale A., Hailu Y., Lindtjorn B., Predictors of early death in a cohort of Ethiopian patients treated with HAART BMC Infectious Diseases 2006 6, article 136
9. Colebunders R., Bastian I., A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis International Journal of Tuberculosis and Lung Disease 2000 4 2 97 107
10. Siddiqi K., Lambert M.-L., Walley J., Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence Lancet Infectious Diseases 2003 3 5 288 296
11. Kibiki G. S., Mulder B., van der Ven A. J. A. M., Sam N., Boeree M. J., Van Der Zanden A., Dolmans W. M. V., Laboratory diagnosis of pulmonary tuberculosis in TB and HIV endemic settings and the contribution of real time PCR for M. tuberculosis in bronchoalveolar lavage fluid Tropical Medicine and International Health 2007 12 10 1210 1217
12. WHO, WHO Three I's Meeting. Report of a Joint WHO HIV/AIDS and TB Department Meeting 2008 Geneva, Switzerland World Health Organization. http://www.who.int/hiv/pub/meetingreports/WHO3Ismeetingreport.pdf
13. Bassett I. V., Wang B., Chetty S., Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa Clinical Infectious Diseases 2010 51 7 823 829
14. Mtei L., Matee M., Herfort O., Bakari M., Horsburgh C. R., Waddell R., Cole B. F., Vuola J. M., Tvaroha S., Kreiswirth B., Pallangyo K., Fordham Von Reyn C., High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania Clinical Infectious Diseases 2005 40 10 1500 1507
15. Lawn S. D., Myer L., Bekker L.-G., Wood R., Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control AIDS 2006 20 12 1605 1612
16. Hermans S. M., Kiragga A. N., Schaefer P., Kambugu A., Hoepelman A. I., Manabe Y. C., Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa PloS One 2010 5 5, article e10527
17. Meintjes G., Rabie H., Wilkinson R. J., Cotton M. F., Tuberculosis-associated immune reconstitution inflammatory syndrome and unmasking of tuberculosis by antiretroviral therapy Clinics in Chest Medicine 2009 30 4 797 810
18. Seddiki N., Sasson S. C., Santner-Nanan B., Munier M., van Bockel D., Ip S., Marriott D., Pett S., Nanan R., Cooper D. A., Zaunders J. J., Kelleher A. D., Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease European Journal of Immunology 2009 39 2 391 403
19. Bourgarit A., Carcelain G., Martinez V., Lascoux C., Delcey V., Gicquel B., Vicaut E., Lagrange P. H., Sereni D., Autran B., Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients AIDS 2006 20 2 F1 F7
20. Elliott J. H., Vohith K., Saramony S., Savuth C., Dara C., Sarim C., Huffam S., Oelrichs R., Sophea P., Saphonn V., Kaldor J., Cooper D. A., Vun M. C., French M. A., Immunopathogenesis and diagnosis of tuberculosis and tuberculosis- associated immune reconstitution inflammatory syndrome during early antiretroviral therapy Journal of Infectious Diseases 2009 200 11 1736 1745
21. Antonelli L. R., Mahnke Y., Hodge J. N., Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome. Blood. In press
22. Meintjes G., Lawn S. D., Scano F., Maartens G., French M. A., Worodria W., Elliott J. H., Murdoch D., Wilkinson R. J., Seyler C., John L., van der Loeff M. S., Reiss P., Lynen L., Janoff E. N., Gilks C., Colebunders R., Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings Lancet Infectious Diseases 2008 8 8 516 523
23. Uganda Ministry of Health and ORC Macro, HIV/AIDS Sero-Behavioural Survey 2004-2005 2006 Calverton, Md, USA Ministry of Health (Uganda) and ORC Macro
24. Uganda National Antiretroviral Treatment and Care Guidelines for Adults, Adolescents and Children 2008 2nd Kampala, Uganda Ministry of Health. http://www.who.int/hiv/amds/ugandamohtreatmentguidelines.pdf
25. Uganda Ministry of Health, Uganda National Policy Guidelines for HIV Counselling and Testing 2003 Kampala, Uganda Ministry of Health
26. WHO, Improving the Diagnosis and Treatment of Smear-Negative Pulmonary and Extrapulmonary Tuberculosis among Adults and Adolescents. Recommendations for HIV Prevalent and Resource-Constrained Settings 2007 Geneva, Switzerland World Health Organization. http://whqlibdoc.who.int/hq/2007/WHOHTMTB2007.379eng. pdf
27. WHO, Obesity: preventing and managing the global epidemic. Report of a WHO Consultation WHO Technical Report Series 2000 894 Geneva, Switzerland World Health Organization. http://whqlibdoc.who.int/trs/WHOTRS894.pdf
28. Breen R. A. M., Smith C. J., Cropley I., Johnson M. A., Lipman M. C. I., Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy? AIDS 2005 19 11 1201 1206
29. Park W. B., Choe P. G., Jo J. H., Kim S.-H., Bang J. H., Kim H. B., Kim N. J., Oh M.-D., Choe K. W., Tuberculosis manifested by immune reconstitution inflammatory syndrome during HAART AIDS 2007 21 7 875 877
30. Valin N., Pacanowski J., Denoeud L., Lacombe K., Lalande V., Fonquernie L., Girard P.-M., Meynard J.-L., Risk factors for 'unmasking immune reconstitution inflammatory syndrome' presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients AIDS 2010 24 10 1519 1525
31. Baalwa J., Mayanja-Kizza H., Kamya M. R., John L., Kambugu A., Colebunders R., Worsening and unmasking of tuberculosis in HIV-1 infected patients after initiating highly active anti-retroviral therapy in Uganda African Health Sciences 2008 8 3 190 195
32. Castelnuovo B., Manaba Y. C., Kiragga A., Kamya M., Easterbrook P., Kambugu A., Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort Clinical Infectious Diseases 2009 49 6 965 972
33. Lawn S. D., Kranzer K., Edwards D. J., McNally M., Bekker L.-G., Wood R., Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy AIDS 2010 24 9 1323 1328
34. Lawn S. D., Myer L., Edwards D., Bekker L.-G., Wood R., Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa AIDS 2009 23 13 1717 1725
35. Collazos J., Martinez M. M., Izquierdo F., Evaluation of acute-phase reactants, immunologic markers and other clinical and laboratory parameters in patients with pneumonia and non-pneumonic lower respiratory tract infections American Journal of Infectious Diseases 2007 3 1 42 45
36. Lawn S. D., Obeng J., Acheampong J. W., Griffin G. E., Resolution of the acute-phase response in west african patients receiving treatment for pulmonary tuberculosis International Journal of Tuberculosis and Lung Disease 2000 4 4 340 344
37. Wilson D., Nachega J., Morroni C., Chaisson R., Maartens G., Diagnosing smear-negative tuberculosis using case definitions and treatment response in HIV-infected adults International Journal of Tuberculosis and Lung Disease 2006 10 1 31 38
38. Hanrahan C. F., Golub J. E., Mohapi L., Tshabangu N., Modisenyane T., Chaisson R. E., Gray G. E., McIntyre J. A., Martinson N. A., Body mass index and risk of tuberculosis and death AIDS 2010 24 10 1501 1508
39. van der Sande M. A. B., Shim van der Loeff M. F., Aveika A. A., Sabally S., Togun T., Sarge-Njie R., Alabi A. S., Jaye A., Corrah T., Whittle H. C., Body mass index at time of HIV diagnosis: a strong and independent predictor of survival Journal of Acquired Immune Deficiency Syndromes 2004 37 2 1288 1294
40. Abdool Karim S. S., Naidoo K., Grobler A., Padayatchi N., Baxter C., Gray A., Gengiah T., Nair G., Bamber S., Singh A., Khan M., Pienaar J., El-Sadr W., Friedland G., Abdool Karim Q., Timing of initiation of antiretroviral drugs during tuberculosis therapy New England Journal of Medicine 2010 362 8 697 706
41. Blanc F. X., Sok T., Laureillard D., Significant enhancement in survival with early (2 weeks) vs. late (8 weeks) initiation of highly active antiretroviral treatment (HAART) in severely immunosuppressed HIV-infected adults with newly diagnosed tuberculosis Proceedings of the 18th International AIDS Conference (IAC '10) July 2010 Vienna, Austria